C-CAMP launches 4th edition of CARB-X supported AMR Quest

New Delhi: C-CAMP is launching the 4th edition of CARB-X supported AMR Quest. The Quest is a unique nation-wide platform dedicated exclusively to innovations in the Antimicrobial Resistance (AMR) domain. It aims to identify, reward, and nurture Indian innovators developing solutions to tackle AMR with a specific focus on ESKAPE Pathogens. The quest presents opportunities for funding and commercialization of idea-stage as well as more mature stage innovations.

C-CAMP Director and CEO, Dr Taslimarif Saiyed said, “AMR Quest is a one-of-a-kind chance for India’s growing AMR innovation community to be counted among the world’s leading AMR innovators and contribute to global efforts against the huge threat posed by AMR. We are excited to have thrown the program open to students and idea-stage innovations this year.”

CARB-X and C-CAMP have partnered to bolster ecosystem development across three funding pillars: preventatives, diagnostics and therapeutics. “Spotlighting and supporting high potential programs from around the world that could someday play a key role in addressing the AMR problem globally is of great importance,” said Betsy Wonderly Trainor, Alliance Director, CARB-X.